Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure. It could be a couple of different things. It could be that the name/symbol change is finally going to be effective? Perhaps another manufacturing partnership? Whatever it is, it's most likely going to be meaningful. Can't see them putting out a teaser on Twitter for something without major positive implications. Whatever it is, let's hope that it moves the needle.
10 Days Until...
— Ecite Motors (@EciteMotors) June 5, 2023
That makes it a good time to accumulate a large position.
Price is dropping back down. LOL.
So much for the rally you predicted.
Click on the Altitrade Partners profile name and it will take you to a page where you can send a private message.
Where do I find my subscription's credit card information and how do I change it to a different card?
That’s probably too generous an offer.
I was thinking more along these lines
Up to 100,000 shares - $0.05 each
Between 100,000 and 499,999 shares - $0.04 each
Over 500,000 shares $ - 0.03 each
I will only purchase shares up to 9.9% of the total shares outstanding.
I am currently at about 6.2%. I am not looking to obtain affiliate status, which is 10% or greater
If you know of anyone who wants to sell shares in a private transction, I would be willing to act as the buyer. They would need to have their shares issued in certificate form and then sign the shares over to me via a stock power.
We have said all along that we look at our investment in Gene Biotherapeutics as if we were investing in a private company. Since we plan on holding our shares for at least another 3-5 years, we don't care about there not being a market for the stock. Why should we care about a lack of liquidity when we have no intention of selling any of our shares for a long time.
Actually, we see this as an advantage, in the sense that it forces us to hang on to our shares, and not be influenced by prevailing market forces. If we were not distracted and didn't get caught up in all of the noise surrounding CELH, we would still likely have the 568,250 shares that we held in our Roth IRA account at an average price of $0.22.
Those shares today would be worth over $74 million
https://i.postimg.cc/52xVycQW/Fidelity-CELH-Position-2-28-2015.jpg
We have confidence that Chris Reinhard will get a deal done to fund a successful Phase 3 clinical trial. The filings are secondary to us. While it may be difficult now, we believe that things will ultimately improve.
Don't underestimate the importance of patience when investing in micro-caps.
It's walking up because investors are finally waking up.
Yes, it looks like Amazon is locked and loaded with all flavors now in stock and available for purchase.
https://www.amazon.com/glucodown
What we find interesting is that existing shareholders fail to understand that by buying additional shares NOW they are helping to protect their own interest in GLUC by potentially minimizing the impact of a reverse split on their EXISTING SHARES.
As we already pointed out, at $0.50 cents the shares would likely need to be reverse split 1-for-10 to reach a price of $5.00. If shares were to reach a $1.00 in price, it would only require a 1-for-5 reverse split in order to get to the $5.00 threshold.
As an existing shareholder what would you rather have happen; a 1-for-10 or a 1-for-5 reverse split?
Investing in a few more shares now could effectively help increase the number of shares that existing investors will have remaining after the reverse split takes place.
If you are already invested in this company, and believe in its future, buying a few more shares now could potentially impact your overall position, in a positive way, by virtue of not having to live with a much larger reverse split, thus increasing the number of shares you would have remaining.
Peace out.
New developments, new products, and new vendors (distribution) all require ramping up inventory levels and spending money on R&D, beta testing, focus groups, etc.
Even PR and IR campaigns require money to implement.
You can't put the cart before the horse.
It's hard to disagree with the fact that GLUC is thinly traded. That said, if buyers did come in en mass the price would definitely move up.
The question then becomes what will attract buyers?
Yesterday's Q3 report should have provided that catalyst. Not sure that there is anything better than an OTC company with strong revenue growth, and a kick-ass product on Amazon.
Add to that, a very compelling capital structure with no debt, low float and a small number of shares outstanding.
Oh, and BTW the company has shown that it can be profitable.
How many OTC pink sheet companies can say that?
Don't you think that if Murray believed what you are saying, he would have taken that specific course of action?
We beg to differ with you. An uplisting to NASDAQ, along with a reverse split, is necessary to move the company forward.
Without capital, Murray cannot expand distribution, since it takes money to produce inventory and new innovative products.
The OTC Market has changed dramatically, for pink sheet companies, as result of SEC Rule 15c2-11. It has made it almost impossible for pink sheet companies to raise capital, since just about every broker/dealer refuses to custody the restricted shares of (SEC) non-reporting companies whose share price is below $5.
Almost every private placement that these types of companies (pink sheet) engage in will result in the accredited investors being unable to sell their shares after the tacking period (usually 2 years for OTC pink sheet companies) expires, since they cannot get the shares custodied at their broker/dealer.
It's not a simple as you think. You are, however correct, in identifying the very tight market conditions for the shares and that it wouldn't take much to get the price of GLUC stock up from here, since the shares are so thinly traded.
The best thing that could happen for GLUC is to see buyers coming in and bidding the price up to $1 or $2. That would dramatically change the dynamics surrounding a reverse split. At a buck, the company would only need to do a 1-for-5 reverse split which is certainly better than a 1-for-10. At $2.50 it looks even better at a 1-for 2 reverse split.
What you fail to understand are the implications and consequences of being a penny stock (defined as less than $5 a share), a non-reporting SEC company and the accompanying difficulties to raise capital.under Rule 15c2-11.
There is more to this than just getting the stock price up to meet the criteria for listing on NASDAQ.
It's far too early to count CRXM out. Yes, things are taking a bit longer than any of us would have expected, but calling the company "toast" is bit premature.
As far as our winning reputation getting tarnished, we have more than a few companies that are in a similar position to CRXM. If just one or two or them can string together some good news, we could capture a spot in the Top Ten on Tip Ranks.
https://www.tipranks.com/experts/bloggers/altitrade-partners
Micro-cap investing requires an inordinate amount of patience and commitment.
Our experience has been that all it takes is the right catalyst, and companies that were once given up for dead, can rise from the ashes, like a Phoenix.
https://altitradepartners.blogspot.com/2021/10/a-lack-of-patience-has-contributed-to.html
https://altitradepartners.blogspot.com/2021/04/these-are-times-that-test-micro-cap.html
When it comes to CRXM, BIOF, CBMJ, GLUC or GEVO, any of them can turn on a dime, given the right catalyst falling into place. For a number of these companies, we are beginning to see signs that there may be light at the end of the tunnel.
Many investors wrote off CELH when they went through some very tough times.
Just take a look at the company today. The stock was $0.22 cents at the end of February 2015. In January of 2021 it traded above $110.00
A lot of investors bailed, and have lived to regret it.
https://chainstoreage.com/news/saving-celsius-cpg-company-comes-back-brink
Blue Biofuels went through a Chapter 11 Bankruptcy and emerged with all of the equity holders being kept whole. How many times does that happen? Rarely, if ever.
https://bioenergyinternational.com/alliance-bioenergy-plus-exits-chapter-11/
Read some of our recent posts on our blog page and on Seeking Alpha
https://altitradepartners.blogspot.com/2022/07/in-back-to-back-days-both-celh-gevo-get.html
https://seekingalpha.com/article/4524301-glucose-health-unique-investment-opportunity-in-global-diabetes-epidemic?source=all_articles_title
Don't be surprised if these companies are much higher in the next few years.
We play in a very speculative sandbox, with distressed micro-caps, but that is why we can accumulate multi-million share positions for pennies on the dollar and wait for these companies to turn around.
We understand that we do is not for everyone, but then we have never seen many investors make big returns by following the crowd.
Not very many people know this but a company with the ticker RLTR is a direct beneficiary of the rise in the price of VAPR shares, by virtue of the fact that RLTR received 20,000,000 shares of VAPR in an agreement dated June 17, 2020.
<<"On June 17, 2020, we entered into a 10-month Production Development and Marketing Agreement with VaporBrands International, Inc. Under this agreement, we provide research and development of a product mix, website development and ongoing website development, an Ecommerce solution, a fulfillment and shipping solution, developing a marketing and promotion plan and wholesale pricing structures on creative development. We were compensated with 20,000,000 restricted shares of common stock fromVaporBrands International, Inc. The shares were valued at $80,000 or $0.004.">>
https://www.otcmarkets.com/otcapi/company/financial-report/332698/content
Those shares, which were valued at $80,000, at the time, are now worth $1,250,000 at today's closing price of $0.0625
RLTR could be a much cheaper way to benefit from any additional appreciation in the price of VAPR stock.
Today RLTR closed at $0.0152.
It doesn't make any sense because you do not understand how to read a Form 4.
Ben did not sell any shares in the open market.
He disposed of 360,000 shares by means of making a private gift.
Bona fide gift
Other Sections 16(b) Exempt Transactions and Small Acquisition Codes. G – Bona fide gift. L – Small Acquisition. W – Acquisition or disposition by will or laws of descent and distribution. Z – Deposit into or withdrawal from voting trust.
https://www.2iqresearch.com/blog/what-is-sec-form-4-and-how-do-you-read-form-4-filings
BTW, May 22, 2022 was a Sunday.
The markets are closed on weekends. He correctly used the closing price of $0.17 cents for BIOF as of Friday, May 20th, which was the last day the shares traded before he made the gift.
Investment Banker H.C. Wainright specializes in these types of situations.
H.C. Wainright was the investment bank for GEVO. Go back and look at their history. It can be done.
https://www.otcmarkets.com/filing/html?id=14166276&guid=2HCwkaYXGUu4B3h
Just siting here watching the Reddit Apes climb all over their latest target, Splash Beverage.
We wrote about the company a few days ago.
https://altitradepartners.blogspot.com/2022/01/splash-beverage-rockets-higher-of-news.html
Can you imagine what could happen if these guys ever targeted BIOF?
Ben doesn't need to do squat. Prove what? To who, you?
He is not required to prove anything. The results speak for themselves.
He is the CEO of a publicly-traded company. He would not make a claim about the company's technology if it wasn't true. The consequences of making false statements are simply too great.
Blue Biofuels Achieves Over 99% Conversion of Cellulose
GLOBENEWSWIRE 2:43 PM ET 1/13/2022
PALM BEACH GARDENS, FL, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Blue Biofuels, Inc.(BIOF) . (the “Company” or “BIOF”) is pleased to announce that it has achieved full conversion ( 99% + ) of king grass cellulosic material to water soluble sugars on a repeatable basis. This conversion occurs with a reaction time of under one minute.
This achievement was accomplished with the Company’s upgraded 4th generation CTS 2.0 (Cellulose to Sugar) reactor system that has been designed to allow further process optimization as compared to earlier systems. Full conversion is the most efficient use of the feedstock possible and exceeds earlier projections. Management believes that this will lead to lower operating and feedstock costs.
This result provides the Company with a strong basis to upscale to the semi commercial 5th generation system and later to the full commercial scale, 6th generation. Blue Biofuels(BIOF) has initiated the development of the 5th generation CTS reactor based on the design parameters of the successful 4th generation system. The Company intends to have the 5th generation operational within the first half of 2022.
Although BIOF is very pleased with these results, they unfortunately took longer than anticipated due to delays encountered in the supply chain caused by the Covid epidemic. The epidemic and accompanying lockdowns and shutdowns at our suppliers and their suppliers caused longer delivery times on the modifications and optimizations of the CTS reactor that were needed on the way to obtaining this result. Going forward, the Company intends to further optimize its supply chain to avoid further delays due to Covid as much as possible.
CEO Ben Slager says, “I am very pleased with this result. It exceeds my expectation and is an excellent basis for cost leadership in the cellulosic sugar and biofuels market place. We also see increased interest for our cellulosic sugars in multiple areas of use, like bio chemicals and bio plastics. We envision a great start in the market in cellulosic bio jet fuels as one of the first volume applications.”
ABOUT OUR CLEAN TECHNOLOGY
CTS (Cellulose to Sugar) technology is a near zero carbon footprint system that can convert virtually any plant material – grasses, wood, paper, farm waste, yard waste, forestry products, fruit casings, nut shells, and the cellulosic portion of municipal solid waste -- into sugars and lignin. Sugars are subsequently processed into biofuels. Lignin may be further converted into biodegradable bioplastics or used in ion exchange resins. CTS stands for Cellulose to Sugar. The CTS process is an independently developed patented and proprietary technology that is fully owned by the Company.
Management believes that biofuel originating from the Company’s CTS process will be eligible to receive generous D3 cellulosic Renewable Fuel Credits (“RINs”) from the US Government. The D3 RIN is currently approximately $3.4/gallon of ethanol, which could be earned in addition to the market price of ethanol. This incentive is offered to all domestic cellulosic fuel producers whose fuel is used in the transportation industry. The Environmental Protection Agency’s newly proposed revised mandate for cellulosic ethanol is 620 million gallons for 2021, and 770 million gallons for 2022.
Information in this document may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Blue Biofuels, Inc. (BIOF) herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Blue Biofuels (BIOF) , Inc. disclaims any obligation to update forward looking statements contained in this press release , except as may be required by law.
Contact:
Ben Slager, CEO
Ben@Bluebiofuels.com
Anthony Santelli, CFO
Anthony@Bluebiofuels.com
SOURCE: Blue Biofuels (BIOF), Inc. www.Bluebiofuels.com
https://finance.yahoo.com/news/blue-biofuels-achieves-over-99-214400614.html
Did any of you possibly give consideration to the fact that management may not be answering phone calls and e-mails because they are busy and, quite frankly, have much bigger fish to fry with moving this company forward?
Please stop all of this nonsense with talk of shareholder lawsuits, and saber rattling. It's counter productive and shows a complete lack of understanding of what it takes to build a business.
This is not our first rodeo, and we can tell you that periodic delays and the resulting silence by management are not unusual in the micro-cap world. In fact, we would say that it is fairly common.
Give these guys some credit for the things that they have accomplished, instead of berating and criticizing them for what they haven't.
We have said our peace, and will now sign off until there is a good reason to post on this message board again.
We will leave everyone with this thought:
Practicing patience is the most important characteristic of being a successful micro-cap investor.
Here are a few things to think about:
https://altitradepartners.blogspot.com/2021/10/a-lack-of-patience-has-contributed-to.html
https://altitradepartners.blogspot.com/2021/04/these-are-times-that-test-micro-cap.html
It's too late to make a Section 475(f) election for this year. A trader must make the mark-to-market election by the original due date (not including extensions) of the tax return for the year prior to the year for which the election becomes effective.
"The statement must be filed not later than the unextended due date of the tax return for the tax year immediately preceding the election year and must be attached either to that return or, if applicable, to a request for an extension of time to file that return. For example, if an individual taxpayer wants the election to be effective for 2010, the statement has to be filed with the individual’s 2009 tax return on or before the due date of April 15, 2010, or with a timely filed request for an extension of the due date for the 2009 return (e.g., Form 4868, Application for Automatic Extension of Time to File U.S. Individual Income Tax Return, filed on or before April 15)."
https://www.thetaxadviser.com/issues/2010/feb/sec475mark-to-marketelection.html
We think that a few things need to be said here.
First of all, we don't make investment calls. We only write about companies that we have a very sizable investment stake in. Unlike other Seeking Alpha contributors who write about almost everything and own nothing, or very little, of what they are writing about.
In short, our focus has always been about the investment activities in our portfolios. We give our friends and family (the people who we are really targeting with our articles) a view into what we are doing, and more importantly why we are doing it.
Everything that gets published, both on Seeking Alpha, and our blog page is based on our opinion at a specific point in time.
We make every attempt to be very clear that we do not provide investment advice to the general public. Additionally, we strive very hard to disclose all of the material risks and potential conflicts of interest that may be present in our published opinions.
The article which you are referring to was titled "Blue Biofuels: Our Absolute Best And No. 1 Microcap Idea For 2021.", with the operative word being "our", as in, for us.
Seeking Alpha articles go through a very exhaustive editorial review process, which normally takes 24-72 hours, and many articles that are submitted never make it onto the Seeking Alpha website.
When we began our January 5th article on Blue Biofuels, the shares were trading sub-10 cents.
Unfortunately, with the release of the article, it attracted an unusual amount of attention and the shares were bid up very rapidly.
We would have much preferred to not have seen that type of parabolic action in the stock price, but we don't control investor's decisions and we cannot control the market.
Our reference to the shares of BIOF being up 100% was only in response to a post by Valeria who decided to chastise us over our investment thesis and article on BIOF. We were not boasting, but simply pointing out that the shares of BIOF haven't done too badly, despite delays and few dashed expectations among investors.
Quite frankly, a lot of time and energy goes into our work, and we have often thought about finding another way to communicate our ideas to our audience of FAF.
CELH and GLUC were both 100-baggers for us, and more than a few investors, along with those same friends and family who read our early articles, decided to come along for the ride by investing in both of those two micro-cap ideas.
We've made a substantial amount of money over the years, and have made the decision to share our knowledge and experience with others, so that they may potentially profit also.
However, we make no warranties nor guarantees; expressed or implied.
We receive no compensation from any of our work, either by the companies that we write about, or persons affiliated with those companies.
We certainly don't expect anything in return from our readers for sharing our ideas, but at the same time we don't expect to be attacked for our work either.
We have often questioned whether we should re-think the idea of continuing to share our work in a public forum.
Sometimes, it just doesn't seem worth it.
Yes, we wrote that article on January 5th when the stock was at $0.12 cents. Today it is sitting at $0.24. That's a gain of 100%.
There are usually a great deal of cross-currents this time of the year, but overall we see a pattern of accumulation in the shares of BIOF.
While this is nothing but pure speculation on our part, it would make a great deal of sense to get the 10-K Annual Report for the period ending 12/31/2020 filed before year-end.
There has been a sudden flurry of heavy buying just in the past 45 minutes.
So far, up over 16% on the day.
A lot of people reading this thread are getting tired of hearing from you too.
Give it a rest, dude. Things are what they are, and no amount of writing or calling management is going to help.
In fact, it would likely do more harm than good by distracting them, and detracting from their time to concentrate on the important stuff like running a company.
Just take a look at how many shares of stock management controls, and then tell me that they are not working hard to get the stock price moving up.
At some point, the tone and tenor of this message board will change and it will become music to the ears of BIOF investors.